Yes, and in fact they are now recommended as an option in the latest American Society of Hematology (ASH) guideline, especially for those who are not at high risk of bleeding and who do not have extensive clot burden:
Oct
26
2021
Oct
26
2021
Yes, and in fact they are now recommended as an option in the latest American Society of Hematology (ASH) guideline, especially for those who are not at high risk of bleeding and who do not have extensive clot burden: